Esophagogastric Junction
5 clinical trials · Condition
◉ Watch Esophagogastric Junction
| Record | Firm | Date |
|---|---|---|
| Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer (NCT04592913) | AstraZeneca | 2020-11-17 |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis (NCT04034251) | National Cancer Institute (NCI) | 2020-06-09 |
| An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers (NCT03662659) | Bristol-Myers Squibb | 2018-10-16 |
| Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology (NCT03092518) | National Cancer Institute (NCI) | 2017-06-05 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma (NCT01962532) | Janssen Research & Development, LLC | 2013-08-21 |
Track Esophagogastric Junction automatically
Every clearance here is in the API, with alerts when new ones post.